Literature DB >> 16700717

EUCAST Technical Note on daptomycin.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700717     DOI: 10.1111/j.1469-0691.2006.01455.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  8 in total

1.  Bacterial strain-to-strain variation in pharmacodynamic index magnitude, a hitherto unconsidered factor in establishing antibiotic clinical breakpoints.

Authors:  Alasdair P MacGowan; Rosy Reynolds; Alan R Noel; Karen E Bowker
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

2.  Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy.

Authors:  B Preiswerk; A Rudiger; J Fehr; N Corti
Journal:  Infection       Date:  2012-07-21       Impact factor: 3.553

3.  Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics.

Authors:  Avinash Singh; Jonathan M Turner; Joshua Tomberg; Alena Fedarovich; Magnus Unemo; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2020-04-06       Impact factor: 5.157

Review 4.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

Review 5.  Antimicrobial resistance in Haemophilus influenzae.

Authors:  Stephen Tristram; Michael R Jacobs; Peter C Appelbaum
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

Review 6.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update.

Authors:  Giuseppe Balice; Claudio Passino; Maria Grazia Bongiorni; Luca Segreti; Alessandro Russo; Marianna Lastella; Giacomo Luci; Marco Falcone; Antonello Di Paolo
Journal:  Antibiotics (Basel)       Date:  2022-07-07

8.  Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).

Authors:  Helio S Sader; Amy A Watters; Thomas R Fritsche; Ronald N Jones
Journal:  BMC Infect Dis       Date:  2007-04-18       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.